We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug-Eluting Stent Makers Try to Brighten Cloudy Market Forecast
Drug-Eluting Stent Makers Try to Brighten Cloudy Market Forecast
January 3, 2007
As 2006 drew to a close, analysts agreed that drug-eluting stent manufacturers face a growing threat to their $5 billion-per-year market after a spate of clinical trial results pointed to an increased risk of clotting, or thrombosis, in patients implanted with the devices.